The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][37] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech.

Aug 27, 2025 · The FDA approval is based on the cumulative body of evidence supporting the safety and efficacy of the Pfizer-BioNTech COVID-19 vaccine, including clinical trial data …

Aug 28, 2024 · The reservation platform Pfizer Prime is now open for orders of COMIRNATY (2024-25 Formula) and Pfizer-BioNTech COVID-19 Vaccine (2024-25 Formula), which are …

Oct 15, 2024 · The Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.

Around the world, Pfizer and BioNTech are working to safely and efficiently distribute COVID-19 vaccines. There are currently no legitimate COVID-19 vaccines produced by any manufacturer …

The webinar series is designed to communicate scientific information, including recent study results to support US healthcare providers’ knowledge regarding COVID-19 and Pfizer …

Do not administer COMIRNATY® (COVID-19 Vaccine, mRNA) to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of COMIRNATY or to …

3 days ago · Researchers identify immune trigger behind myocarditis after COVID-19 vaccination A Pfizer and BioNTech COVID-19 vaccine shot.

Nov 4, 2025 · Two types of COVID-19 vaccines are recommended for use in the United States: mRNA vaccines (Moderna and Pfizer-BioNTech) and a protein subunit vaccine (Novavax).

Aug 27, 2025 · The FDA approval is based on the cumulative body of evidence supporting the safety and efficacy of the Pfizer-BioNTech COVID-19 vaccine, including clinical trial data …